Evidence mapPaperPMID 40559713Full record

ArticleTropical medicine and infectious disease2025

Burden in Colombia of COVID-19 in Adults and the Associated Clinical Characteristics: A Retrospective Database Analysis.

Jair Arciniegas, Juan Manuel Reyes, Jhon Bolaños-López, Julia Regazzini Spinardi, Jingyan Yang, Farzaneh Maleki, Farley Johanna Gonzalez, Carlos Jose Bello, Ana Catalina Herrera-Díaz, Omar Escobar and 6 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jair ArciniegasPfizer, Bogotá 111211, Cundinamarca, Colombia.ORCID 0009-0006-2575-3991
Juan Manuel ReyesPfizer, Bogotá 111211, Cundinamarca, Colombia.ORCID 0000-0003-0806-7173
Jhon Bolaños-LópezSuramericana IPS-Sura, Medellín 050015, Antioquia, Colombia.ORCID 0000-0003-1157-5347
Julia Regazzini SpinardiPfizer, Sao Paulo 04230-040, Brazil.ORCID 0000-0002-4324-0317
Jingyan YangPfizer, New York, NY 10001, USA.ORCID 0000-0001-5523-649X
Farzaneh MalekiPfizer, New York, NY 10001, USA.
Farley Johanna GonzalezSuramericana IPS-Sura, Medellín 050015, Antioquia, Colombia.ORCID 0009-0006-5147-8778
Carlos Jose BelloSuramericana IPS-Sura, Medellín 050015, Antioquia, Colombia.ORCID 0000-0001-8205-4317
Ana Catalina Herrera-DíazSuramericana IPS-Sura, Medellín 050015, Antioquia, Colombia.
Omar EscobarPfizer, Bogotá 111211, Cundinamarca, Colombia.ORCID 0000-0002-4939-0850
Andrea RubioPfizer, Bogotá 111211, Cundinamarca, Colombia.
Monica GarciaPfizer, Bogotá 111211, Cundinamarca, Colombia.
Luz Eugenia Pérez JaramilloSuramericana IPS-Sura, Medellín 050015, Antioquia, Colombia.
Jorge La RottaPfizer, Bogotá 111211, Cundinamarca, Colombia.
Moe H KyawPfizer, New York, NY 10001, USA.ORCID 0000-0002-0258-6645
Carlos Fernando MendozaPfizer, Mexico City 05120, Mexico.

Funding

Pfizer Not applicable
6 · The paper itself

Abstract

Studies on the burden of COVID-19 cases in Colombia have focused on specific populations and short timeframes. A retrospective observational study was conducted on adult patients aged 18 diagnosed with COVID-19 who received inpatient and/or outpatient medical care at a large health maintenance organization, to evaluate the burden of COVID-19 cases in Colombia (from March 2020 to January 2023) and associations with demographic and clinical characteristics. COVID-19 cases were identified with ICD-10 codes and confirmed by a laboratory test. The statistical analysis focused on descriptors of the frequency of events. A multivariate regression model was used to identify factors associated with severe conditions and death. Of the 953,661 cases detected, most cases (~79%) were mild or moderate (handled as outpatients). There were 20.1% (N = 191,260) severe cases and 0.9% (N = 8841) critical cases. Most COVID patients were unvaccinated (94.6%) and had, on average, one comorbidity. Hypertension (19.1%), immunocompromised condition (23.8%), mental health conditions (15%), obesity (10.8%), and cancer (11.2%) were the common prevalent comorbidities. The presence of comorbidity increased the risk of severe or critical COVID-19. COVID-19 cases were associated with the lack of vaccination and comorbidities. Effective vaccination strategies are needed to reduce the burden of COVID-19 in Colombia and, considering budgetary constraints, it is advisable to prioritize the elderly or populations with underlying conditions.

Indexed as

adultburden of diseaseColombiaCOVID-19incidencerisk factors

Identifiers

PMID40559713
PMCPMC12197621

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.